Top Markets
#1 Black Phoenix Black Phoenix +824.20%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.37%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.97%
#4 Prom Prom +20.14%
#5 Magma Finance Magma Finance +19.82%
#6 SAFEcoin SAFEcoin +19.77%
#7 Beam Beam +18.79%
#8 pipedog pipedog +17.11%
#9 Bless Bless +17.08%
#10 YFSX YFSX +15.57%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Classement en actions #6138
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Prix de l'action
$154.04
Capitalisation boursière
$2.21B
Changement (1 jour)
-0.19%
Changement (1 an)
172.88%
Pays
US
Échange Palvella Therapeutics, Inc. (PVLA)

Catégorie

Healthcare
Historique du prix de l'action pour Palvella Therapeutics, Inc. (PVLA)
Prix de clôture le plus élevé : $151.69 le 2026-08-01

Prix de clôture le plus bas : $13.11 le 2024-12-01
Historique du prix de l'action de Palvella Therapeutics, Inc. de 2024 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 7.48%
2025 649.84%
2024 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.65 40.75%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.04%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $143.63 472.23%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH